Studies have found pathological laboratory test results in COVID-19 patients, especially in those with severe COVID-19, such as elevated leukocyte counts, reduced lymphocyte counts and elevated levels of C-reactive protein, D-dimer levels, ferritin and lactate dehydrogenase, indicating hypercoagulability that could potentially provoke vessel occlusion and embolism [15, 26]. The gene discussed is CRP; the disease is COVID-19.